IRIS
DE FILIPPI, ROSARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.742
NA - Nord America 1.114
EU - Europa 1.104
SA - Sud America 225
AF - Africa 18
OC - Oceania 5
Totale 4.208
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.072
SG - Singapore 988
RU - Federazione Russa 604
CN - Cina 381
BR - Brasile 196
IT - Italia 175
HK - Hong Kong 170
DE - Germania 99
FI - Finlandia 97
VN - Vietnam 77
IN - India 47
KR - Corea 29
GB - Regno Unito 23
CA - Canada 17
NL - Olanda 17
IE - Irlanda 15
MX - Messico 15
AT - Austria 14
SE - Svezia 14
BD - Bangladesh 12
FR - Francia 11
AR - Argentina 9
ES - Italia 7
JP - Giappone 7
PL - Polonia 6
CL - Cile 5
EC - Ecuador 5
IQ - Iraq 5
MK - Macedonia 5
CH - Svizzera 4
CO - Colombia 4
TR - Turchia 4
UA - Ucraina 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
PA - Panama 3
AL - Albania 2
BE - Belgio 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
IL - Israele 2
OM - Oman 2
PK - Pakistan 2
TN - Tunisia 2
UY - Uruguay 2
BF - Burkina Faso 1
BO - Bolivia 1
CD - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
ID - Indonesia 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
ME - Montenegro 1
MG - Madagascar 1
MR - Mauritania 1
MU - Mauritius 1
PE - Perù 1
PF - Polinesia Francese 1
PG - Papua Nuova Guinea 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
SA - Arabia Saudita 1
SD - Sudan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VE - Venezuela 1
YE - Yemen 1
ZW - Zimbabwe 1
Totale 4.208
Salva come PNG Salva come JPEG
Città #
Singapore 484
Hong Kong 170
Hefei 166
Moscow 160
Santa Clara 156
Chandler 132
Ashburn 74
Millbury 45
Beijing 44
Helsinki 43
Ho Chi Minh City 40
Princeton 36
Boston 34
Nanjing 30
Seoul 29
Buffalo 28
Napoli 28
The Dalles 28
Des Moines 26
Los Angeles 26
Naples 26
Milan 22
Falkenstein 19
Redondo Beach 19
São Paulo 18
Kochi 16
Munich 16
Nanchang 14
Mumbai 12
Seattle 12
Weng 12
Hanoi 11
Lappeenranta 11
Shenyang 11
Lawrence 10
Mexico City 10
New York 10
Nuremberg 10
Jacksonville 9
Ottawa 9
Amsterdam 8
Changsha 8
Corridonia 8
Rio de Janeiro 8
Vienna 7
Freiburg im Breisgau 6
Hebei 6
Karlsruhe 6
Montreal 6
Orem 6
San Francisco 6
Tokyo 6
Turku 6
Warsaw 6
Wilmington 6
Karlskrona 5
Poplar 5
Porto Alegre 5
Trieste 5
Brasília 4
Brooklyn 4
Chennai 4
Falls Church 4
Jiaxing 4
London 4
Phoenix 4
Tianjin 4
Ahmedabad 3
Atlanta 3
Belo Horizonte 3
Bengaluru 3
Campinas 3
Charlotte 3
Da Nang 3
Dallas 3
Dublin 3
Fortaleza 3
Geneva 3
Goiânia 3
Kronberg 3
Kunming 3
Lanzhou 3
Minneapolis 3
Niederaula 3
Panama City 3
Prilep 3
Quito 3
Raleigh 3
Rome 3
Stockholm 3
Tashkent 3
Treviso 3
Volta Redonda 3
Vũng Tàu 3
Araguaína 2
Atibaia 2
Baghdad 2
Bentley 2
Betim 2
Boardman 2
Totale 2.300
Salva come PNG Salva come JPEG
Nome #
Il Sistema Immunitario 114
Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study 103
Dacarbazine-induced immunogenicity of a murine leukemia is attenuated in cells transfected with mutated K-ras gene. 103
Immunotherapies Targeting CD123 and CD303: A New Frontier in Treating Blastic Plasmacytoid Dendritic Cell Neoplasm 92
Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab 87
Elevation of clonal serum free light chains in patients with HIV-negative primary effusion lymphoma (PEL) and PEL-like lymphoma. 86
Aging and the hemopoietic system. 85
DAT-negative hemolytic anemia in a chronic lymphocytic leukemia patient treated with alemtuzumab. 84
A human T cell line engineered to secrete chimeric monoclonal antibody. 84
The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape. 82
Combined effects of immunity and antitumor drugs against cancer. II. In vitro studies with cis-diamminedichloroplatinum in a human leukemia system. 82
Post-exposure prophylaxis with sotrovimab for Omicron (B.1.1.529) SARS-CoV-2 variant during the aplastic phase of autologous stem cell transplantation 81
Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia. 81
Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononuclear cells. 81
HODGKIN LYMPHOMA THERAPY - Cessione una tantum, irrevocabile ed in via esclusiva a Mundipharma EDO GmbH/PURDUE del proprio diritto di titolarità al brevetto, domanda nr. US 2018/0098969A1 la cui procedura di concessione è tuttora in itinere e dove la sottoscritta compare tra i co-inventori. 81
Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma. 78
Combined effects of immunity and antitumor drugs against cancer. I. In vivo studies with cis-diamminedichloroplatinum and cyclophosphamide in mouse models. 78
Expression of the Brain Transcription Factor OTX1 Occurs in a Subset of Normal Germinal-Center B Cells and in Aggressive Non-Hodgkin Lymphoma. 77
Induction of human cytotoxic T cell lines directed against point-mutated p21 ras-derived synthetic peptides 75
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab 75
Effect of the combined treatment with 5-fluorouracil, gamma-interferon or folinic acid on carcinoembryonic antigen expression in colon cancer cells. 74
Macrophage colony-stimulating factor enhancement of antibody-dependent cellular cytotoxicity against human colon carcinoma cells. 73
In vitro tumour cell growth inhibition: a comparative study between allosensitized cytotoxic T lymphocytes and lymphokine activated killer cells. 72
Combined effects of host antitumor immune responses and chemotherapy. Studies with hexamethylmelamine. 71
Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma. 70
Transfer of the IL-6 gene into a human colorectal carcinoma cell line and consequent enhancement of tumor antigen expression. 69
Enhanced interleukin-2 production in human tumor-infiltrating lymphocytes engineered by 3'-truncated interleukin-2 gene. 68
Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma. 68
Circulating dendritic cells deficiencies as a new biomarker in classical Hodgkin lymphoma 68
Drug-induced changes of carcinoembryonic antigen expression in human cancer cells: effect of 5-fluorouracil. 67
Growth factor-dependent activation of alphavbeta3 integrin in normal epithelial cells: implications for tumor invasion. 65
Dendritic cells in hematological malignancies. 61
The role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells. 60
Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. 58
Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy. 58
Role of vincristine in immunochemotherapy of leukemia in mouse or human models. 57
The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies? 56
Exposure to obinutuzumab does not affect outcomes of SARS-CoV-2 infection in vaccinated patients with newly diagnosed advanced-stage follicular lymphoma 55
Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined Therapies 54
Breakthrough in Blastic Plasmacytoid Dendritic Cell Neoplasm Cancer Therapy Owing to Precision Targeting of CD123 54
Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I Trial 53
A phase II study of dose-dense and dose-intense ABVD (ABVDDD-DI ) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma. 53
Original article: Immuno-chemotherapy of advanced colorectal cancer with alpha-2a interferon and 5-Fluorouracil immunopharmacological studies 52
TNF receptor-associated factor 1 is a positive regulator of the NF-kappaB alternative pathway. 52
Tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukemia predicts clinical response. 52
Immuno-chemotherapy of advanced colorectal cancer with alpha-2a interferon and 5-fluorouracil. Immunopharmacological studies. 52
Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy. 52
The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia. 51
Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas. 51
Patients with multiple myeloma infected with COVID-19 during autologous stem cell transplantation 49
RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma. 49
90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years 49
Long-term complete remission in a patient with high-risk primary mediastinal B-cell lymphoma and iatrogenic symptomatic bradycardia after only two courses of DA-EPOCH-R followed by chemo-free treatment 48
ICOSLG Is Associated with Anti-PD-1 and Concomitant Antihistamine Treatment Response in Advanced Melanoma 48
A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumor DNA 46
Response and toxicity to cytarabine therapy in leukemia and lymphoma: From dose puzzle to pharmacogenomic biomarkers 44
Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients 43
In vitro cultures of pathological thyroid cells: a powerful diagnostic technique. 43
Growth factor-dependent activation of ?v?3 integrin in normal epithelial cells: Implications for tumor invasion 41
Childhood Therapy–Related Acute Myeloid Leukemia with t(16;21)(q24;q22)/RUNX1-CBFA2T3 After a Primitive Neuroectodermal Tumor of the Chest Wall 40
The combination of body mass index and serum creatinine levels predicts survival in patients with Hodgkin lymphoma treated with nivolumab in the CheckMate 205 study 39
Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis. 39
Overview of targeted drugs for mature B-cell non-hodgkin lymphomas 36
Long-term efficacy and safety of dose-dense and dose-intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15-year follow-up of the ABVDDD-DI phase II study 35
Effect of the combined treatment with 5-fluorouracil, γ-interferon or folinic acid on carcinoembryonic antigen expression in colon cancer cells 34
A Combined Proteomic and Transcriptomic Signature Is Predictive of Response to Anti-PD-1 Treatment: A Retrospective Study in Metastatic Melanoma Patients 34
Gene-expression signature predicts autoimmune toxicity in metastatic melanoma 29
Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma 28
PET2-Adapted Therapy in Patients With Advanced-Stage Hodgkin Lymphoma Treated With Frontline ABVD: Searching for the Baby in the Bathwater 28
null 14
The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies? 11
Totale 4.282
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.084
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.084
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 9 4 10 0 0 0 1
2021/2022209 2 0 1 0 0 2 5 5 22 3 52 117
2022/2023317 47 29 19 10 75 31 9 34 42 6 13 2
2023/2024209 4 34 27 18 6 3 7 20 20 7 40 23
2024/20251.638 82 121 11 6 86 143 181 85 112 141 518 152
2025/20261.606 293 329 260 225 428 71 0 0 0 0 0 0
Totale 4.282